Clinical Trials · NCT00395746
Effect of Liraglutide in Combination With Sulfonylurea (SU) on Blood Glucose Control in Subjects With Type 2 Diabetes
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 264
- Start date
- Oct 2006
- Locations
- 1 site, Japan
- Primary endpoint
- Glycosylated Haemoglobin A1c (HbA1c) After 24 Weeks of Treatment